Zoetis Net Income 2011-2020 | ZTS

Zoetis annual/quarterly net income history and growth rate from 2011 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Zoetis net income for the quarter ending March 31, 2020 was $0.423B, a 35.58% increase year-over-year.
  • Zoetis net income for the twelve months ending March 31, 2020 was $1.611B, a 16.07% increase year-over-year.
  • Zoetis annual net income for 2019 was $1.5B, a 5.04% increase from 2018.
  • Zoetis annual net income for 2018 was $1.428B, a 65.28% increase from 2017.
  • Zoetis annual net income for 2017 was $0.864B, a 5.24% increase from 2016.
Zoetis Annual Net Income
(Millions of US $)
2019 $1,500
2018 $1,428
2017 $864
2016 $821
2015 $339
2014 $583
2013 $504
2012 $436
2011 $245
2010 $110
Zoetis Quarterly Net Income
(Millions of US $)
2020-03-31 $423
2019-12-31 $384
2019-09-30 $433
2019-06-30 $371
2019-03-31 $312
2018-12-31 $345
2018-09-30 $347
2018-06-30 $384
2018-03-31 $352
2017-12-31 $81
2017-09-30 $298
2017-06-30 $247
2017-03-31 $238
2016-12-31 $154
2016-09-30 $239
2016-06-30 $224
2016-03-31 $204
2015-12-31 $22
2015-09-30 $189
2015-06-30 $-37
2015-03-31 $165
2014-12-31 $126
2014-09-30 $166
2014-06-30 $136
2014-03-31 $155
2013-12-31 $105
2013-09-30 $131
2013-06-30 $128
2013-03-31 $140
2012-12-31 $-10
2012-09-30 $162
2012-06-30 $173
2012-03-31 $111
2011-12-31
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $73.383B $6.260B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $58.389B 10.18
Astellas Pharma (ALPMY) Japan $30.180B 15.29
UCB SA (UCBJF) Belgium $24.702B 0.00
Eisai (ESALY) Japan $24.615B 21.34
Merck (MKGAF) Germany $17.008B 22.31
Catalent (CTLT) United States $13.967B 53.99
Grifols, S.A (GRFS) Spain $13.118B 16.03
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.669B 0.00
Neurocrine Biosciences (NBIX) United States $11.423B 44.41
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $8.246B 43.84
Orion OYJ (ORINY) Finland $7.077B 24.56
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.906B 0.00
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.195B 9.91
United Therapeutics (UTHR) United States $5.170B 11.95
Arrowhead Pharmaceuticals (ARWR) United States $4.517B 493.11
Hypermarcas (HYPMY) Brazil $4.293B 15.79
Evotec AG (EVTCY) Germany $4.065B 109.55
Nektar Therapeutics (NKTR) United States $3.930B 0.00
FibroGen (FGEN) United States $3.780B 0.00
ChemoCentryx (CCXI) United States $3.385B 0.00
PTC Therapeutics (PTCT) United States $3.121B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.504B 12.12
Sage Therapeutics (SAGE) United States $2.410B 0.00
Cronos Group (CRON) Canada $2.376B 67.90
Pacira BioSciences (PCRX) United States $2.312B 47.32
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.820B 0.00
Xencor (XNCR) United States $1.814B 0.00
Corcept Therapeutics (CORT) United States $1.759B 17.44
USANA Health Sciences (USNA) United States $1.706B 16.08
Indivior (INVVY) United States $1.655B 20.55
Ironwood Pharmaceuticals (IRWD) United States $1.567B 11.99
Heron Therapeutics (HRTX) United States $1.521B 0.00
Akebia Therapeutics (AKBA) United States $1.510B 0.00
Revolution Medicines (RVMD) United States $1.433B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.410B 15.19
Zogenix (ZGNX) United States $1.348B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.256B 0.00
Karyopharm Therapeutics (KPTI) United States $1.233B 0.00
Esperion Therapeutics (ESPR) United States $1.116B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.102B 0.00
VAXART, INC (VXRT) United States $1.009B 0.00
Translate Bio (TBIO) United States $0.988B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.941B 42.01
Tilray (TLRY) Canada $0.928B 0.00
Altimmune (ALT) United States $0.872B 0.00
Endo (ENDP) Ireland $0.832B 1.29
BioCryst Pharmaceuticals (BCRX) United States $0.776B 0.00
ImmunoGen (IMGN) United States $0.726B 0.00
Trillium Therapeutics (TRIL) Canada $0.620B 0.00
Collegium Pharmaceutical (COLL) United States $0.572B 0.00
Radius Health (RDUS) United States $0.566B 0.00
Aerie Pharmaceuticals (AERI) United States $0.552B 0.00
Siga Technologies (SIGA) United States $0.528B 0.00
Ardelyx (ARDX) United States $0.527B 0.00
Molecular Templates (MTEM) United States $0.526B 0.00
Flexion Therapeutics (FLXN) United States $0.523B 0.00
TherapeuticsMD (TXMD) United States $0.516B 0.00
Innate Pharma SA (IPHYF) France $0.495B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.492B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.472B 18.43
Crinetics Pharmaceuticals (CRNX) United States $0.462B 0.00
DURECT (DRRX) United States $0.460B 0.00
Ocular Therapeutix (OCUL) United States $0.448B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.427B 10.32
Rigel Pharmaceuticals (RIGL) United States $0.410B 0.00
Organogenesis Holdings (ORGO) United States $0.394B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.368B 0.00
Calithera Biosciences (CALA) United States $0.343B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.316B 0.00
IMV INC (IMV) Canada $0.313B 0.00
PROFOUND MEDICL (PROF) Canada $0.304B 0.00
MEI Pharma (MEIP) United States $0.302B 0.00
Harpoon Therapeutics (HARP) United States $0.301B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.284B 0.00
Concert Pharmaceuticals (CNCE) United States $0.282B 0.00
Redhill Biopharma (RDHL) Israel $0.275B 0.00
OptiNose (OPTN) United States $0.262B 0.00
Lannett Co Inc (LCI) United States $0.253B 5.54
CASI Pharmaceuticals (CASI) United States $0.235B 0.00
Rafael Holdings (RFL) United States $0.227B 0.00
Nature's Sunshine Products (NATR) United States $0.202B 26.61
Taiwan Liposome (TLC) Taiwan $0.198B 0.00
KalVista Pharmaceuticals (KALV) United States $0.195B 0.00
Nivalis Therapeutics (ALPN) United States $0.195B 0.00
Onconova Therapeutics (ONTX) United States $0.192B 0.00
Aquestive Therapeutics (AQST) United States $0.191B 0.00
Heat Biologics (HTBX) United States $0.176B 0.00
Jounce Therapeutics (JNCE) United States $0.163B 3.89
Matinas Biopharma Holdings (MTNB) United States $0.161B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.130B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.121B 0.00
Xeris Pharmaceuticals (XERS) United States $0.116B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.111B 0.00
CTI BioPharma (CTIC) United States $0.109B 0.00
Biomerica (BMRA) United States $0.109B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.109B 0.00
Champions Oncology (CSBR) United States $0.108B 0.00
Otonomy (OTIC) United States $0.105B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.105B 0.00
MediWound (MDWD) Israel $0.105B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.102B 0.00
Recro Pharma (REPH) United States $0.097B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.096B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.093B 0.00
Hemispherx BioPharma (AIM) United States $0.092B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.090B 0.00
Aclaris Therapeutics (ACRS) United States $0.089B 0.00
ElectroCore (ECOR) United States $0.089B 0.00
Lipocine (LPCN) United States $0.082B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.071B 0.00
SCYNEXIS (SCYX) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.066B 0.00
Sundial Growers (SNDL) Canada $0.063B 0.00
PolarityTE (PTE) United States $0.062B 0.00
Infinity Pharmaceuticals (INFI) United States $0.054B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 30.90
Addex Therapeutics (ADXN) Switzerland $0.051B 0.00
Novan (NOVN) United States $0.049B 0.00
IsoRay (ISR) United States $0.045B 0.00
Natural Alternatives (NAII) United States $0.045B 0.00
GTx (ONCT) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Mannatechorporated (MTEX) United States $0.042B 7.92
AgeX Therapeutics (AGE) United States $0.041B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.041B 0.00
Jaguar Animal Health (JAGX) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 83.18
NovaBay Pharmaceuticals (NBY) United States $0.038B 0.00
Can-Fite Biopharma (CANF) Israel $0.038B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.036B 0.00
Neos Therapeutics (NEOS) United States $0.033B 0.00
India Globalization Capital (IGC) United States $0.030B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
RXi Pharmaceuticals (PHIO) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 34.29
Regulus Therapeutics (RGLS) United States $0.014B 0.00
China SXT Pharmaceuticals (SXTC) China $0.014B 0.00
Shineco (TYHT) China $0.013B 0.00
Midatech Pharma (MTP) United Kingdom $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Vical (BBI) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00